Posted by Michael Wonder on 20 Nov 2015
FDA approves Ninlaro, new oral medication to treat multiple myeloma
20 November 2015 - Today the U.S. FDA granted approval for Ninlaro (ixazomib) for use in combination with two other therapies to treat people with multiple myeloma who have received at least one prior therapy.
For more details, go to: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm473771.htm
